The Beauty Health Company
The Beauty Health Company (SKIN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
skin · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 14 Wall Street analysts in the past 3 months
Hold
14 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$2.00
Consensus
$1.53
+150.8% upside
Low
$1.00
Median: $1.6 · Last Close: $0.61
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$1.53
150.8% upside
High Target
$2
227.9%
Low Target
$1
63.9%
Current Price
$0.61
as of today
Based on analyst price targets, the SKIN stock price prediction for the next 12 months ranges from $1 to $2. The consensus SKIN price forecast of $1.53 implies 150.8% upside from the current price of $0.61.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.58 | ↓ 4.82% |
1-day model range: $0.56–$0.61. Peak: $0.61 (-4.82%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · SKIN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-20 | Roth Capital | Maintains | Buy→Buy |
| 2026-05-01 | Canaccord Genuity | Maintains | Hold→Hold |
| 2026-03-16 | TD Cowen | Maintains | Hold→Hold |
| 2026-03-13 | Canaccord Genuity | Maintains | Hold→Hold |
| 2026-01-21 | TD Cowen | Maintains | Hold→Hold |
| 2025-09-22 | TD Cowen | Maintains | Hold→Hold |
| 2025-08-01 | Stifel | Maintains | Hold→Hold |
| 2025-05-05 | Canaccord Genuity | Maintains | Hold→Hold |
| 2025-03-13 | Canaccord Genuity | Maintains | Hold→Hold |
| 2024-11-13 | Canaccord Genuity | Maintains | Hold→Hold |
Wall Street analysts have recently issued updated ratings on The Beauty Health Company (SKIN) stock. Of the recent 74 rating actions, 1 were upgrades and 10 were downgrades. 14 analysts currently cover SKIN.
Analyst Recommendation Trends
SKIN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$328M
↑ 13.3% YoY
Revenue Next Year
$297M
↓ 9.5% YoY
EPS This Year
$-0.28
EPS Next Year
$-0.07
↓ 74.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast SKIN EPS of $-0.28 for the current fiscal year, based on estimates from 3 analysts. The SKIN revenue forecast is $328M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SKIN stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SKIN price target is $1.53 (+150.8% upside), with an analyst consensus of Hold.
The SKIN short-term stock prediction for tomorrow is $0.58 (-4.82%). The SKIN stock prediction for 2030 projects a range of $0–$0.
The Beauty Health Company trades on NASDAQ under the ticker SKIN. The SKIN stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 29% of covering analysts.
Frequently asked questions
SKIN forecast · 8 questionsAccording to 14 Wall Street analysts, the average 12-month SKIN price target is $1.53, with a high forecast of $2.00 and a low of $1.00. The median price target is shown in the chart above when available. This implies +150.8% potential upside from the current price of $0.61.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.